NASDAQ:TLIS
Talis Biomedical Corporation Stock News
$9.30
+0.0400 (+0.432%)
At Close: May 10, 2024
Talis Biomedical appoints former Abbott executive as CEO
09:59pm, Monday, 15'th Nov 2021 Seeking AlphaTalis Biomedical Corporation (TLIS) CEO Kim Popovits on Q3 2021 Results - Earnings Call Transcript
09:40pm, Monday, 15'th Nov 2021
Talis Biomedical Corporation (TLIS) CEO Kim Popovits on Q3 2021 Results - Earnings Call Transcript
Talis Biomedical EPS beats by $0.18, beats on revenue
09:14pm, Monday, 15'th Nov 2021 Seeking AlphaTalis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress
09:05pm, Monday, 15'th Nov 2021 Intrado Digital Media
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific
Talis Biomedical (TLIS) Scheduled to Post Quarterly Earnings on Monday
06:20am, Sunday, 14'th Nov 2021 Dakota Financial News
Talis Biomedical (NASDAQ:TLIS) will issue its quarterly earnings data after the market closes on Monday, November 15th. Analysts expect the company to announce earnings of ($1.67) per share for the quarter. Parties that wish to register for the companys conference call can do so using this link. Shares of TLIS stock opened at $5.66 on []
Talis Biomedical (TLIS) Stock: Why The Price Surged Today
12:13pm, Monday, 08'th Nov 2021
The stock price of Talis Biomedical Corp (NASDAQ: TLIS) increased by over 15% during intraday trading today. This is why it happened.
LOS ANGELES--(BUSINESS WIRE)---- $TLIS #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a national investor rights law firm, continues its investigation on behalf of Talis Biomedical Corporation
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
01:32pm, Tuesday, 14'th Sep 2021
BENSALEM, Pa.--(BUSINESS WIRE)---- $TLIS #CLASSACTION--Law Offices of Howard G. Smith continues its investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ:
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Talis Biomedical Corporation (“Talis” or the
LOS ANGELES--(BUSINESS WIRE)---- $TLIS #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on
The Law Offices of Frank R. Cruz Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
03:15pm, Thursday, 09'th Sep 2021
LOS ANGELES--(BUSINESS WIRE)---- $TLIS #investors--The Law Offices of Frank R. Cruz Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
The Law Offices of Frank R. Cruz Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
08:25pm, Tuesday, 31'st Aug 2021
LOS ANGELES--(BUSINESS WIRE)---- $TLIS #investors--The Law Offices of Frank R. Cruz Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
Talis Biomedical Announces CEO Transition
04:30pm, Monday, 30'th Aug 2021
Kim Popovits to serve as interim CEO Kim Popovits to serve as interim CEO
Talis Biomedical's (TLIS) CEO Brian Coe on Q2 2021 Results - Earnings Call Transcript
09:18pm, Tuesday, 10'th Aug 2021
Talis Biomedical's (TLIS) CEO Brian Coe on Q2 2021 Results - Earnings Call Transcript
Talis Biomedical Corporation (TLIS) CEO Brian Coe on Q1 2021 Results - Earnings Call Transcript
09:28pm, Tuesday, 11'th May 2021
Talis Biomedical Corporation (TLIS) CEO Brian Coe on Q1 2021 Results - Earnings Call Transcript
